Farid Boumédiène

Dietary BMAA Exposure in an Amyotrophic Lateral Sclerosis Cluster from Southern France

Estelle Masseret, Sandra Anne Banack, Farid Boumédiène et al. · PLoS ONE · 2013 · 142 citations · Full text

Pharmacy, Marine Sciences, Toxicology +15

Population‐based epidemiology of amyotrophic lateral sclerosis (<scp>ALS</scp>) in an ageing<scp>E</scp>urope – the<scp>F</scp>rench register of<scp>ALS</scp>in<scp>L</scp>imousin (<scp>FRAL</scp>im register)

Benôıt Marin, Bello Hamidou, Philippe Couratier et al. · European Journal of Neurology · 2014 · 65 citations

Medicine, Neurology, Neuroscience +12

Variation in worldwide incidence of amyotrophic lateral sclerosis: a meta-analysis.

Benôıt Marin, Farid Boumédiène, Giancarlo Logroscino et al. · HAL (Le Centre pour la Communication Scientifique Directe) · 2016 · 48 citations

Life Sciences, Neurology, Neuroscience +11

Searching for a link between the L-BMAA neurotoxin and amyotrophic lateral sclerosis: a study protocol of the French BMAALS programme

Aurélie Delzor, Philippe Couratier, Farid Boumédiène et al. · BMJ Open · 2014 · 29 citations · Full text

Life Sciences, Neurology, Neuroscience +14

Prevalence of epilepsy in the 15 years and older in Benin: A door-to-door nationwide survey

Luce‐Perrine Yemadje, Dismand Houinato, Farid Boumédiène et al. · Epilepsy Research · 2012 · 23 citations

Medicine, Neurology, Epidemiology +5